These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 39187151)
1. Effects of TET2-mediated methylation reconstruction on A2058 melanoma cell sensitivity to matrix stiffness in a 3D culture system. Shen Z; Liu Z; Li M; Han L; Wang J; Wu X; Sang S Exp Cell Res; 2024 Sep; 442(1):114224. PubMed ID: 39187151 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma. Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070 [TBL] [Abstract][Full Text] [Related]
3. DNA hypermethylation is associated with invasive phenotype of malignant melanoma. Koroknai V; Szász I; Hernandez-Vargas H; Fernandez-Jimenez N; Cuenin C; Herceg Z; Vízkeleti L; Ádány R; Ecsedi S; Balázs M Exp Dermatol; 2020 Jan; 29(1):39-50. PubMed ID: 31602702 [TBL] [Abstract][Full Text] [Related]
4. Li C; Peng C; Jiang Z; Hu H; Lin C; Gao Y; Liu D; Sun B; Wang D DNA Cell Biol; 2022 Feb; 41(2):169-178. PubMed ID: 34962153 [No Abstract] [Full Text] [Related]
5. Activation of Hypoxia Inducible Factor-1 Alpha-Mediated DNA Methylation Enzymes (DNMT3a and TET2) Under Hypoxic Conditions Regulates S100A6 Transcription to Promote Lung Cancer Cell Growth and Metastasis. Wang T; Zhu G; Wang B; Hu M; Gong C; Tan K; Jiang L; Zhu X; Geng Y; Li L Antioxid Redox Signal; 2024 Jul; 41(1-3):138-151. PubMed ID: 38299557 [No Abstract] [Full Text] [Related]
6. Knockdown of Delta-like 3 restricts lipopolysaccharide-induced inflammation, migration and invasion of A2058 melanoma cells via blocking Twist1-mediated epithelial-mesenchymal transition. Ding X; Li F; Zhang L Life Sci; 2019 Jun; 226():149-155. PubMed ID: 30981764 [TBL] [Abstract][Full Text] [Related]
7. Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression. Kamdar S; Isserlin R; Van der Kwast T; Zlotta AR; Bader GD; Fleshner NE; Bapat B Clin Epigenetics; 2019 Mar; 11(1):54. PubMed ID: 30917865 [TBL] [Abstract][Full Text] [Related]
8. TET2 Is Downregulated in Early Esophageal Squamous Cell Carcinoma and Promotes Esophageal Squamous Cell Malignant Behaviors. Wen H; Liu XB; Zhu ZD; Jin S; Gao YJ; Tong Q; Li SB Dig Dis Sci; 2024 Jul; 69(7):2462-2476. PubMed ID: 38653944 [TBL] [Abstract][Full Text] [Related]
9. TET2 regulates extranodal NK/T cell lymphoma progression through regulation of DNA methylation. Xiang C; Gao L; Tao Q; Chen Z; Zhao S; Liu W Hematol Oncol; 2024 Jul; 42(4):e3295. PubMed ID: 38979860 [TBL] [Abstract][Full Text] [Related]
10. Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis. Rasmussen KD; Jia G; Johansen JV; Pedersen MT; Rapin N; Bagger FO; Porse BT; Bernard OA; Christensen J; Helin K Genes Dev; 2015 May; 29(9):910-22. PubMed ID: 25886910 [TBL] [Abstract][Full Text] [Related]
11. PML Recruits TET2 to Regulate DNA Modification and Cell Proliferation in Response to Chemotherapeutic Agent. Song C; Wang L; Wu X; Wang K; Xie D; Xiao Q; Li S; Jiang K; Liao L; Yates JR; Lee JD; Yang Q Cancer Res; 2018 May; 78(10):2475-2489. PubMed ID: 29735542 [TBL] [Abstract][Full Text] [Related]
12. Ten-eleven translocation 2 demethylates the Li X; Wu C; Shen Y; Wang K; Tang L; Zhou M; Yang M; Pan T; Liu X; Xu W J Biol Chem; 2018 Jun; 293(26):10059-10070. PubMed ID: 29773648 [TBL] [Abstract][Full Text] [Related]
13. TET2 functions as a resistance factor against DNA methylation acquisition during Epstein-Barr virus infection. Namba-Fukuyo H; Funata S; Matsusaka K; Fukuyo M; Rahmutulla B; Mano Y; Fukayama M; Aburatani H; Kaneda A Oncotarget; 2016 Dec; 7(49):81512-81526. PubMed ID: 27829228 [TBL] [Abstract][Full Text] [Related]
14. Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma. Cheng PF; Shakhova O; Widmer DS; Eichhoff OM; Zingg D; Frommel SC; Belloni B; Raaijmakers MI; Goldinger SM; Santoro R; Hemmi S; Sommer L; Dummer R; Levesque MP Genome Biol; 2015 Feb; 16(1):42. PubMed ID: 25885555 [TBL] [Abstract][Full Text] [Related]
15. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL. Poole CJ; Lodh A; Choi JH; van Riggelen J Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538 [TBL] [Abstract][Full Text] [Related]
16. Embryonic stem cell microenvironment suppresses the malignancy of cutaneous melanoma cells by down-regulating PI3K/AKT pathway. Wang C; Wang X; Liu J; Huang Z; Li C; Liu Y; Sang X; Yang L; Wang S; Su Y; Liu C; Liu Y; Wang Z Cancer Med; 2019 Aug; 8(9):4265-4277. PubMed ID: 31173492 [TBL] [Abstract][Full Text] [Related]
17. TET2 is involved in DNA hydroxymethylation, cell proliferation and inflammatory response in keratinocytes. Liu X; Wang X; Liu N; Zhu K; Zhang S; Duan X; Huang Y; Jin Z; Jaypaul H; Wu Y; Chen H Mol Med Rep; 2020 Apr; 21(4):1941-1949. PubMed ID: 32319620 [TBL] [Abstract][Full Text] [Related]
18. Repression of TGF-beta signaling by the oncogenic protein SKI in human melanomas: consequences for proliferation, survival, and metastasis. Medrano EE Oncogene; 2003 May; 22(20):3123-9. PubMed ID: 12793438 [TBL] [Abstract][Full Text] [Related]
19. Methylation and loss of Secreted Frizzled-Related Protein 3 enhances melanoma cell migration and invasion. Ekström EJ; Sherwood V; Andersson T PLoS One; 2011 Apr; 6(4):e18674. PubMed ID: 21494614 [TBL] [Abstract][Full Text] [Related]
20. Bioengineered 3D brain tumor model to elucidate the effects of matrix stiffness on glioblastoma cell behavior using PEG-based hydrogels. Wang C; Tong X; Yang F Mol Pharm; 2014 Jul; 11(7):2115-25. PubMed ID: 24712441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]